Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

NCT02664389 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02664389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02664389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
Lead sponsor
University Hospital, Rouen
Phase
Not applicable
Overall status
Terminated
Start date
February 1, 2016
Completion date
March 15, 2017
Enrollment
289 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, multiple primary malignant tumours, ovarian cancer, pediatric cancers